TT Capital Partners, NovaQuest Capital Management, and Frist Cressey Ventures Invests in InformedDNA

We represented TT Capital Partners (TTCP), NovaQuest Capital Management (NovaQuest) and Frist Cressey Ventures in its recapitalization and growth equity investment in InformedDNA, the nation’s largest provider of genetic services. InformedDNA will use the capital to continue scaling its technology-enabled, genetics expert services, as well as to expand its staff of genetic counselors. Terms of the transaction were not disclosed.

The TTCP and NovaQuest Capital Management deal teams were led by Ryan Thomas and included corporate attorneys Ryan Hoffman, Bo Cook, Gardner Bell and Oliver Peglow. Philip Lewis counseled on tax issues while Shannon Wiley and Whitney Snow advised on healthcare regulatory issues; Felix Dowsley and Vincent Lillegard advised on financing-related matters; Shelley Thomas, Emily Burrows and Stefanie Colletier advised on intellectual property matters; and Kimberly Veirs advised on labor and employment matters. Michael Holley also advised Frist Cressey Ventures in its minority investment.

You Also May Be Interested In:

  • Representation of Twin River Worldwide Holdings, Inc. (NYSE: TRWH) in its definitive agreement to acquire Jumer’s Casino & Hotel, from Delaware North Companies Gaming & Entertainment, Inc., for $120 million in cash

     

    We represented Twin River Worldwide Holdings, Inc. in its definitive agreement to acquire Jumer's Casino & Hotel, from Delaware North...
    Client Type: Public Company
  • Representation of Southern Ear, Nose, and Throat and Allergy (SENTA) Partners, an ENT and allergy management services organization backed by Shore Capital Partners, in its affiliation with Atlanta Allergy & Asthma, the largest allergy practice in Georgia

    We represented Southern Ear, Nose, and Throat and Allergy (SENTA) Partners, an ENT and allergy management services organization backed by...
    Client Type: Private Company
  • Representation of Truxton Trust, a subsidiary of financial holding company, Truxton Corporation (OTCPK: TRUX), in the sale of $15 million aggregate principal amount of fixed-to-floating rate subordinated notes due in 2030

    We represented Truxton Trust in the sale of $15 million aggregate principal amount of fixed-to-floating rate subordinated notes due in...
    Client Type: Public Company